NIH preclinical study suggests FDA-approved tetracycline-based antibiotics may slow infection and reduce neurological problems among patients with Zika infection.
from Medindia Health News https://ift.tt/3nTRJgq
LATEST HEALTH NEWS
Reviewed by MZ Digital Marketing Agency
on
November 25, 2020
Rating: 5
No comments
Thanks for comment via will connect you within 24 hours.
No comments
Thanks for comment via will connect you within 24 hours.